State-backed insurance programmes would fund drugs for obese patients without separate health conditions
Today’s classes are as much about stress relief as spirituality. The feeling of elation is an added bonus, too. Time to get it om
Africa leads decline but cases must fall faster to meet target of ending designation of Aids as public health threat by 2030
Trump nominee has caused concern in the industry due to his desire to reduce spending on medicines
Scientific research into how plastics affect the body is in its early days
Information Commissioner warns improper use of popular messaging app could be ‘hugely problematic’ for NHS
Jay Bhattacharya at the NIH would be the latest ally of Robert F Kennedy Jr to take a role overseeing US healthcare
Wealthy and developing nations in disagreement on crucial issues as climate summit nears its close
First, rude. Second, here’s my diary of not joining the queue for the super drug
Effort to understand cellular functions promises to unlock crucial information about personal health
Group, which has faced multiple US lawsuits, hit with fresh claims that its products caused cancer
Robert F Kennedy Jr’s appointment is characteristic of Trump’s hostility to expertise
Simon Kuper and Anjana Ahuja select their must-read titles
UK company says launch of chewable goods, presence in supermarkets and anti-obesity drugs have driven demand
Danish company expects data to show that CagriSema cuts weight by 25 per cent in just over a year
This week’s issue takes in revolutionary supplements, rare Scandi maximalism – and a reactionary restaurant that wants to go back in time
New York Times has sued European Commission over its refusal to release president’s exchanges with Pfizer chief
Vaccine sceptic and former Democrat is the latest controversial nomination for cabinet post
As anxieties about mental health increase, many headteachers are prohibiting phone use for students. Should the government make that mandatory?
Sharp rise in cases over 30 years compounded by millions of people lacking access to medication, Lancet study finds
The bathhouse is back, from old-school hang-outs to sleek new spas
We go to the source of a 30mn-strong phenomenon
In-house counselling is becoming more common, but the country’s high-pressure corporate culture persists
People prone to breast cancer and diabetes among beneficiaries of early testing
Data suggests that the long-term drag on health service delivery may be finally lifting
